Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Safety Study Using Pentamidine in Patients With Pancreatic Cancer Undergoing Standard Therapy

This study has been completed.
Information provided by:
Oncozyme Pharma Inc. Identifier:
First received: December 16, 2008
Last updated: June 27, 2011
Last verified: June 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2011
  Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)